期刊文献+

Ⅱ、Ⅳ、Ⅴ、Ⅹ型磷脂酶A_2 mRNA在大鼠淋巴器官中的分布 被引量:2

Distribution of Phospholipase A_2 Types Ⅱ,Ⅳ,Ⅴ and Ⅹ mRNA in Rat Lymphoid Organs
下载PDF
导出
摘要 目的探讨Ⅱ、Ⅳ、Ⅴ、Ⅹ型磷脂酶A2(PLA2)mRNA在正常大鼠淋巴器官中的分布情况,了解各型PLA2在细菌感染所致的免疫反应中可能发挥的作用。方法从大鼠的淋巴器官骨髓、胸腺、淋巴结和脾的组织匀浆中提取总RNA,合成第1链cDNA,利用PCR扩增上述各型PLA2DNA,PCR产物经2%琼脂糖凝胶电泳检测。结果在大鼠淋巴器官中均能检测到Ⅱ、Ⅳ型PLA2mRNA,Ⅱ型PLA2mRNA的含量比Ⅳ型PLA2mRNA高;只在脾中检测到Ⅴ型PLA2mRNA;在各淋巴器官中均未检测到Ⅹ型PLA2mRNA。结论实验表明,Ⅱ型和Ⅳ型PLA2广泛存在于中枢和外周淋巴器官中,含量丰富,在宿主防御细菌感染的过程中,除了参与先天免疫外,很可能参与获得性免疫反应;Ⅴ型PLA2mRNA存在于脾脏中,也可能参与获得性免疫反应,但不如Ⅱ型和Ⅳ型PLA2重要。 OBJECTIVE To investigate the distribution of phospholipase A2 (PLA2) types Ⅱ, Ⅳ, Ⅴ and Ⅹ mRNA in rat lymphoid organs, including bone marrow, thymus, lymph node and spleen, in order to increase our knowledge in their possible role in bacterial infection. METHODS The total RNA was extracted from lymphoid organs homogenate. Then the first-strand cDNA was synthesized and PLA2 DNA was amplified by PCR. The PCR products were analyzed by 2% agarose gel electrophoresis. RESULTS PLA2 types Ⅱ and Ⅳ mRNA were detectable in bone marrow, thymus, lymph node and spleen. But the content of PLA2 type Ⅱ mRNA was richer than type Ⅳ. PLA2 types Ⅴ mRNA was only detectable in spleen. PLA2 types Ⅹ mRNA was not detectable in rat lymphoid organs. CONCLUSIONS PLA2 types Ⅱ and Ⅳ mRNA is found in both central and peripheral lymphoid organs. In the process of host defense against bacterial infection, besides the role in innate immunity, the two types of PLA2 may take part in adaptive immunity. PLA2 type Ⅴ mRNA is only found in spleen and may play a role in adaptive immunity, too. However, it may not important as types PLA2 Ⅱ and Ⅳ.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2006年第3期267-269,255,共4页 Chinese Journal of Nosocomiology
基金 广西自然科学基金资助(桂科回9920012) 国家人事部留学回国人员科技资助
关键词 磷脂酶A2 细菌感染 MRNA 淋巴器官 Phospholipase A2 Bacterial infection mRNA Lymphoid organs
  • 相关文献

参考文献11

  • 1苏启表,梁宁生,蒙子卿.大鼠血小板型磷脂酶A_2的研究进展[J].国外医学(临床生物化学与检验学分册),2004,25(1):52-54. 被引量:3
  • 2Koprivnjak T, Peschel A, Gelb MH, et al. Role of charge properties of bacterial envelope in bactericidal action of humangroup Ⅱ A phospholipase As against Staphylococcus aureus[J]. J Biol Chem,2002,277(49) :47636-47644.
  • 3苏启表,梁宁生,杨帆,陆益,李艳,卢凤玲,蒙子卿.Ⅱ型、Ⅴ型、Ⅹ型磷脂酶A_2 mRNA在大鼠消化系统中的分布[J].中华消化杂志,2004,24(8):503-504. 被引量:5
  • 4梁宁生,李艳,杨帆,陆益,蒙子卿.重组人血小板型磷脂酶A_2杀菌作用的研究[J].中华医院感染学杂志,2004,14(10):1081-1083. 被引量:17
  • 5梁宁生,刘滔滔,蒙子卿.血小板型磷脂酶A_2的研究进展[J].国外医学(临床生物化学与检验学分册),2001,22(1):3-4. 被引量:11
  • 6Gronroos JO, Laine VJ, Janssen MJ, et al. Bactericidal properties of group ⅡA and group Ⅴ secretory phospholipase A(2)[J]. J Immunol,2001,166(6):4029-4034.
  • 7Koduri RS, Gronroos JO, Laine VJ, etal. Bactericidal properties of human and murine groups Ⅰ , Ⅱ, Ⅴ, Ⅹ, and Ⅻ secretory phospholipase A(2) [J]. J Biol Chem, 2000,277 (8) : 5849-5857.
  • 8Nyman KM, Ojala P, Laine VJ, et al. Distribution of group Ⅱ phospholipase A2 protein and mRNA in rat tissues[J]. JHistochem Cytochem, 2000,48(11) : 1469-1478.
  • 9梁宁生,苏启表,杨帆,陆益,李艳,卢凤玲,蒙子卿.血小板型磷脂酶A_2mRNA在大鼠体内的分布[J].中华医院感染学杂志,2004,14(3):258-260. 被引量:3
  • 10Boilard E, Bourgoin SG, Bernatchez C, et al, Interaction of low molecular weight group Ⅱ A phospholipase A2 with apoptotic human T cells: role of heparan sulfate proteoglycans[J]. FASEB J,2003,17(9) :1068-1080.

二级参考文献30

  • 1姚春艳,府伟灵.葡萄球菌医院感染的耐药性分析[J].中华医院感染学杂志,2004,14(1):104-106. 被引量:86
  • 2[1]Levy O. Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents[J]. Blood, 2000,96(8):2664-2672.
  • 3[3]Weinrauch Y, Elsbach P, Madsen LM, et al. The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2[J]. J Clin Invest,1996,97(1):250-257.
  • 4[4]Weinrauch Y, Abad C, Liang NS, et al.Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group ⅡA phospholipase A2[J]. J Clin Invest, 1998,102(3):633-638.
  • 5[1]Weinrauch Y, Abad C, Liang NS, et al.Mobilization of potent plasma bactericidal activity during systemic bacterial challenge.Role of group ⅡA phospholipase A2[J].J Clin Invest, 1998, 102(3): 633-638.
  • 6[2]Koprivnjak T, Peschel A, Gelb MH, et al.Role of charge properties of bacterial envelope in bactericidal action of human group ⅡA phospholipase A2 against Staphylococcus aureus[J].J Biol Chem, 2002, 277(49): 47636-47644.
  • 7[5]Newton CR, Graham A.PCR[M].2nd Ed.Oxford: BIOS Scientific Publishers Limited, 1997.161-165.
  • 8[7]Valentin E, Singer AG, Ghomashchi F, et al.Cloning and recombinant expression of human group ⅡF-secreted phospholipase A(2)[J].Biochem Biophys Res Commun, 2000, 279(1): 223-228.
  • 9[8]Nyman KM, Ojala P, Laine VJ, et al.Distribution of group Ⅱ phospholipase A2 protein and mRNA in rat tissues[J].J Histochem Cytochem, 2000, 48(11): 1469-1478.
  • 10Molloy GY,Rattray M,William RJ.Genes encoding multiple forms of phospholipase A2 are expressed in rat brain.Neurosci Lett,1998,258(3):139-142.

共引文献31

同被引文献20

  • 1姚春艳,府伟灵.葡萄球菌医院感染的耐药性分析[J].中华医院感染学杂志,2004,14(1):104-106. 被引量:86
  • 2姜鹏,王建春,钱桂生.过氧化物酶增殖体激活受体α mRNA在急性肺损伤大鼠肺组织表达的变化[J].中国急救医学,2005,25(6):439-441. 被引量:3
  • 3Koike K,Yamamoto Y,Hori Y,et al. Group Ⅱ A phospholipase A2 mediates lung injury in intestinal isehemia-reperfusion. Ann Surg, 2000,232 : 90 - 97.
  • 4Neidlinger NA, Hirvela ER, Skinner RA,et al. Postinjury serum secretory phospholipase A2 correlates with hypoxemia and clinical status at 72 hours. J Am Coil Surg, 2005,200:173-178.
  • 5Baek SH, Lim JH, Park DW, et al. Group Ⅱ A secretory phospholipase A (2) stimulates inducible nitric oxide synthase expression via ERK and NF-κB in macrophages. Eur J Immunol, 2001,31:2709-2717.
  • 6Ge RL, Matsuzawa Y, Takeoka M, et al. Low pulmonary diffusing capacity in subjects with acute mountain sickness. Chest, 1997,111:58-64.
  • 7Perez RO, Bresciani C, Jacob CE, et al. Negative pressure postextubation pulmonary edema complicating appendectomy in a young patient : case report. Current Surgery ,2004,61:463-465.
  • 8Brown CM, Dutsch M, Hecht MJ, et al. Assessment of cerebrovascular and cardiovascular responses to lower body negative pressure as a test of cerebral autoregulation. Neurol Sci, 2003, 208: 71-78.
  • 9Murphy DJ, Renninger JP, Ju HS. A model of orthostatic hypotension in the conscious monkey using lower body negative pressure. Pharmacol Toxicol Methods, 2006, 3: 106-115.
  • 10Brown CM, Dutsch M, Hecht M J, et al. Assessment of cerebrovascular and cardiovascular responses to lower body negative pressure as a test of cerebral autoregulation. Neurol Sci, 2003, 208 : 71-78.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部